Agios Pharmac

AGIO

Current ValuationThe current P/E ratio is -4.62, within the reasonable range, cheaper than 57.64% of the time in the past 5 years, and the industry ranks 366/604, the industry Median -2.14.

-4.62xP/E
Stock price$31.81Earnings per share$-6.89

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
020406080

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x30x60x90x120x150x
P/E ratio
Name/Symbol
GILDUSGilead Sciences
-57.85x148.64%$187.44B
MRNAUSModerna
-28.51x15.53%$89.83B
CSLLYUSCSL Limited
-23.93x--$61.70B
NTRAUSNatera
-300.29x6.99%$57.76B
RVMDUSRevolution Medicines
-23.00x62.39%$40.67B
ROIVUSRoivant Sciences
-96.15x146.49%$25.60B
BNTXUSBioNTech SE
-12.44x19.72%$24.36B
INSMUSInsmed
-25.10x74.21%$21.97B
SMMTUSSummit Therapeutics
-16.39x19.55%$14.03B
BBIOUSBridgebio Pharma
-18.47x28.48%$12.78B
IBRXUSImmunityBio
-11.22x151.32%$11.14B
MDGLUSMadrigal Pharma
-33.53x51.06%$10.90B
PCVXUSVaxcyte
-10.56x49.36%$11.23B
TWSTUSTwist Bioscience
-76.94x28.88%$10.52B
KYMRUSKymera Therapeutics
-31.20x5.25%$9.35B
ARWRUSArrowHead Pharma
-27.70x36,308.30%$8.86B
CYTKUSCytokinetics
-9.78x6.46%$8.75B
ABVXUSAbivax SA
-16.50x22.49%$7.68B
SYREUSSpyre Therapeutics
-50.30x45.67%$7.56B
IONSUSIonis Pharma
-13.31x50.60%$7.52B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.